Two doses of recombinant zoster vaccine (RZV) are associated with a reduced risk for herpes zoster ophthalmicus (HZO), acute ...

The latest announcement is out from GlaxoSmithKline ( (GB:GSK) ).

August 19, 2025) – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) (“PreveCeutical” or the “Company“), a health sciences company that develops innovative options for preventive and ...

GSK PLC closed 14.28% short of its 52-week high of £16.79, which the company reached on September 9th.

In late April, the FDA notified SCYNEXIS that the clinical hold on ibrexafungerp had been lifted and concluded that the Phase 3 MARIO study could resume. The MARIO study is a Phase 3 trial evaluating ...

Gain insights from Mersana Therapeutics' Q2 2025 earnings call. Highlights include Emi-Le advancements in TNBC, $15M milestone, and a $77M cash position.

Spero Therapeutics, Inc. (NASDAQ: SPRO) Q2 2025 Earnings Call Transcript August 12, 2025 Spero Therapeutics, Inc. beats ...

GSK and CureVac will together receive $740 million, as well as royalties on sales of COVID-19 vaccines in the US ...

The 40 Under 40, Rami Fakhouri of Goldman Ismail is honored for his work in products liability.

The GSK Flovent example highlights the consequences for patients and pharma of the decision to eliminate the Medicaid rebate ...

British drugmaker GSK said on Monday that the U.S. Food and Drug Administration has accepted its application for priority ...